These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10610465)

  • 21. [First comparison of 2 statins shows: only radical LDL lowering stops coronary atherosclerosis].
    Einecke D
    MMW Fortschr Med; 2003 Dec; 145(51-52):38. PubMed ID: 14974329
    [No Abstract]   [Full Text] [Related]  

  • 22. Is aggressive lipid-lowering therapy preferable to angioplasty in stable coronary artery disease?
    Ellis PM
    Med J Aust; 2001 Nov; 175(9):492-3. PubMed ID: 11758081
    [No Abstract]   [Full Text] [Related]  

  • 23. Atorvastatin for acute coronary syndromes.
    Schwartz GG; Olsson AG; Ezekowitz MD; Ganz P; Oliver MF; Waters D; Zeiher A; Chaitman BR
    JAMA; 2001 Aug; 286(5):533-5. PubMed ID: 11476650
    [No Abstract]   [Full Text] [Related]  

  • 24. [High lowering of lipids can melt coronary plaques -- is coronary disease reversible?].
    Einecke D
    MMW Fortschr Med; 2006 Jun; 148(24):4-5. PubMed ID: 16850796
    [No Abstract]   [Full Text] [Related]  

  • 25. [Atorvastatin].
    Kajinami K; Takekoshi N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():598-604. PubMed ID: 11347138
    [No Abstract]   [Full Text] [Related]  

  • 26. Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
    LaRosa JC; Grundy SM; Waters DD; Shear C; Barter P; Fruchart JC; Gotto AM; Greten H; Kastelein JJ; Shepherd J; Wenger NK;
    N Engl J Med; 2005 Apr; 352(14):1425-35. PubMed ID: 15755765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Avoid angioplasty by lowering cholesterol?
    Health News; 1999 Aug; 5(10):5. PubMed ID: 15352287
    [No Abstract]   [Full Text] [Related]  

  • 28. Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia.
    Malhotra HS; Goa KL
    Drugs; 2001; 61(12):1835-81. PubMed ID: 11693468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of atherosclerosis progression.
    Young JH
    Lancet; 2001 Jul; 358(9278):328-9. PubMed ID: 11501528
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE).
    Deedwania P; Stone PH; Bairey Merz CN; Cosin-Aguilar J; Koylan N; Luo D; Ouyang P; Piotrowicz R; Schenck-Gustafsson K; Sellier P; Stein JH; Thompson PL; Tzivoni D
    Circulation; 2007 Feb; 115(6):700-7. PubMed ID: 17283260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Atorvastatin in treatment of patients with coronary heart disease and dislipidemiya and high general risk: efficiency and safety estimation. Design and main results of ATLANTIKA].
    Mareev VIu; Belenkov IuN; Oganov RG; Barbik-Zhagar B
    Kardiologiia; 2008; 48(11):4-13. PubMed ID: 19076074
    [No Abstract]   [Full Text] [Related]  

  • 32. [Coronary disease patient has already LDL of 100 mg/dl. Why lipid lowering is still worthwhile].
    MMW Fortschr Med; 2005 Mar; 147(12):4. PubMed ID: 15832778
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of atorvastatin on peripheral endothelial function and systemic inflammatory markers in patients with stable coronary artery disease.
    Alber HF; Frick M; Süssenbacher A; Dörler J; Dichtl W; Stocker EM; Pachinger O; Weidinger F
    Wien Med Wochenschr; 2007 Feb; 157(3-4):73-8. PubMed ID: 17340064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical therapy versus revascularization: the atorvastatin versus revascularization treatment AVERT trial.
    Waters DD
    Can J Cardiol; 2000 Jan; 16 Suppl A():11A-3A. PubMed ID: 10653925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized evaluation of atorvastatin in patients with coronary heart disease: a serial intravascular ultrasound study.
    Yamada T; Azuma A; Sasaki S; Sawada T; Matsubara H;
    Circ J; 2007 Dec; 71(12):1845-50. PubMed ID: 18037734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Coronary heart disease patient reaches LDL level of 100 mg/dl with atorvastatin: how do you continue treatment next year?].
    Weizel A; Sawicki PT
    MMW Fortschr Med; 2004 Dec; 146(51-52):14, 16. PubMed ID: 15675236
    [No Abstract]   [Full Text] [Related]  

  • 37. Believe-it then PROVE-IT.
    Jackson G
    Int J Clin Pract; 2004 Apr; 58(4):325-6. PubMed ID: 15161113
    [No Abstract]   [Full Text] [Related]  

  • 38. Possible involvement of advanced glycation end products in carry-over benefits of atorvastatin in ASCOT-BPLA.
    Yamagishi S
    Eur Heart J; 2008 Aug; 29(15):1922. PubMed ID: 18523056
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol.
    Kanadaşi M; Cayli M; Demirtaş M; Inal T; Demir M; Koç M; Avkaroğullari M; Dönmez Y; Usal A; Alhan CC; San M
    Heart Vessels; 2006 Sep; 21(5):291-7. PubMed ID: 17151816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early anticoagulant effect of atorvastatin.
    Pignatelli P; Sanguigni V; Buchetti B; Lenti L; Violi F
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):e145; author reply e145-6. PubMed ID: 16306433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.